Kira E. Olander
Impact in
- Immunology top 10%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune cells in cancer
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
-
- Immune Cell Function and Interaction 2
- Galectins and Cancer Biology 1
- Oncology 3
- CAR-T cell therapy research 2
- Co-authors
- Arvin Iracheta‐Vellve (1 shared paper)Clara H. Wolfe (1 shared paper)Margaret D. Zimmer (1 shared paper)Juan Dubrot (1 shared paper)Thomas G. R. Davis (1 shared paper)Hans W. Pope (1 shared paper)Kyle M. Ockerman (1 shared paper)Peter M. Allen (1 shared paper)
- Journals
- Immunity (2 papers)Nature (2 papers)Nature Immunology (1 paper)Nature Genetics (1 paper)Science (1 paper)
- Partner nations
- United StatesThailand
In The Last Decade
Kira E. Olander
6 papers receiving 667 citations
Kira E. Olander's Hit Papers
Peers
Comparison fields: 5 of 58
- Immunology 270
- Oncology 219
- Molecular Biology 359
- Cancer Research 61
- Aging 7
Countries citing papers authored by Kira E. Olander
This map shows the geographic impact of Kira E. Olander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kira E. Olander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kira E. Olander more than expected).
Fields of papers citing papers by Kira E. Olander
This network shows the impact of papers produced by Kira E. Olander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kira E. Olander. The network helps show where Kira E. Olander may publish in the future.
Co-authors
The 21 scholars most cited alongside Kira E. Olander, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity Hit paper breakdown → | 2021 | 271 |
| 2 | 2022 | 149 | |
| 3 | 2023 | 121 | |
| 4 | 2021 | 65 | |
| 5 | 2024 | 62 | |
| 6 | 2024 | 13 | |
| 7 | 2025 | 0 | |
| 8 | 2026 | 0 |
About Kira E. Olander
Kira E. Olander is a scholar working on Immunology, Oncology, Business and International Management, Physiology and Molecular Biology, having authored 8 papers that have together received 681 indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (4 papers), RNA modifications and cancer (2 papers), CAR-T cell therapy research (2 papers), Epigenetics and DNA Methylation (2 papers), Immune Cell Function and Interaction (2 papers), Innovation and Socioeconomic Development (1 paper), Gene Regulatory Network Analysis (1 paper) and Galectins and Cancer Biology (1 paper). The work is most often cited by research in Immunology (270 citations), Oncology (219 citations), Molecular Biology (359 citations), Cancer Research (61 citations) and Aging (7 citations). Kira E. Olander has collaborated with scholars based in United States and Thailand. Frequent co-authors include Arvin Iracheta‐Vellve, Clara H. Wolfe, Margaret D. Zimmer, Juan Dubrot, Thomas G. R. Davis, Hans W. Pope, Kyle M. Ockerman, Peter M. Allen, Sarah Kate Lane-Reticker and W. Nicholas Haining. Their work appears in journals such as Immunity, Nature, Nature Immunology, Nature Genetics and Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.